Detail akcie Agilent Tech online

Business Summary: Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Financial Summary: BRIEF: For the six months ended 30 April 2025, Agilent Technologies Inc revenues increased 4% to $3.35B. Net income decreased 19% to $533M. Revenues reflect Life Sciences and Diagnostics Markets segment increase of 6% to $1.3B, Agilent CrossLab segment increase of 4% to $1.41B, United States segment increase of 6% to $1.35B, Europe segment increase of 2% to $905M, Asia Pacific segment increase of 2% to $1.1B.